The article examines evidence on appropriate empirical antimicrobial therapy in critically ill patients, focusing on a predefined DIANA study sub-analysis and findings from other infection cohorts.
Approach:
DIANA sub-analysis: A predefined analysis included 845 critically ill patients with microbiologically confirmed infections; 87.7% received appropriate empirical therapy.
Supporting studies: The article also describes findings from community-onset sepsis, bloodstream infection, and community-onset bacteremia cohorts.
Key Findings:
In the DIANA sub-analysis, appropriate empirical therapy was independently associated with improved survival (adjusted odds ratio 1.83), as well as more antimicrobial-free and mechanical ventilation-free days.
Survival gains in DIANA were most evident among patients with SOFA scores of 3–9; the authors describe this finding as hypothesis-generating.
Other cited cohorts associated appropriate therapy with lower mortality, faster defervescence, or shorter hospital stays.
The article distinguishes appropriate pathogen coverage from narrow-spectrum treatment and notes that broad-spectrum or combination regimens may have contributed to DIANA’s high appropriateness rate.
Interpretation:
The article presents appropriate empirical therapy as associated with better outcomes, while noting that appropriateness involves more than in vitro activity and that observational findings may be affected by residual confounding. It distinguishes appropriate coverage from narrow-spectrum treatment and cautions against unnecessary broad-spectrum exposure.
Limitations:
The DIANA sub-analysis was observational and may be affected by residual confounding.
It included patients with microbiologically confirmed infections, excluding culture-negative cases in which adequacy could not be defined.
The highest-severity group (SOFA > 9) may not have had sufficient statistical power to demonstrate a significant difference.
Conclusion:
The article argues for pursuing timely, clinically appropriate empirical therapy while avoiding unnecessary broad-spectrum exposure, followed by rapid reassessment.
